Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous tirzepatide with microwave device for body contouring in Asians
TCTR20260320002Phase 4Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Feb 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on TCTR20260320002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260320002.